Duvalisibon

duvelisib

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Duvalisibon, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma [Phase 2]